Digital Content 
NEWS #PharmaBuzz
21 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-therapeutics-highlights-progress-in-recast-dcis-platform-trial-at-early-detection-research-conference-laura-esserman-md-mba-to-discuss-active-surveillance-strategy-and-novel-endocrine-agents-302589184.html
13 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-advances-global-patent-strategy-for-z-endoxifen-with-new-protection-in-israel-and-ongoing-renewals-302581338.html
08 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-therapeutics-announces-regulatory-strategy-aimed-at-accelerating-development-of-low-dose-z-endoxifen-for-breast-cancer-risk-reduction-302548910.html
20 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-therapeutics-selects-psi-as-contract-research-organization-for-pivotal-dose-ranging-study-of-z-endoxifen-in-metastatic-breast-cancer-302534234.html
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-therapeutics-announces-full-results-from-ispy-2-endocrineoptimization-substudy-evaluating-lowdose-zendoxifen-302455086.html
28 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/atossa-therapeutics-and-quantum-leap-healthcare-provide-enrollment-update-for-z-endoxifen-arm-of-ongoing-i-spy-2-clinical-trial-301865328.html
Share 